CymitQuimica logo

CAS 1791420-09-1

:

Sortieren nach

Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 Produkte.
  • Dilpacimab

    CAS:
    A humanized dual-variable domain antibody targets both delta-like ligand 4 (DLL4) and VEGF pathways

    Ref: 3D-CLA1529

    ne
    Nachfragen
  • Dilpacimab

    CAS:
    Dilpacimab (ABT165) is a dual-variable antibody that targets DLL4 and VEGF pathways, showing potential in cancer research by blocking angiogenesis and Notch.
    Reinheit:95% - 97.7% (SDS-PAGE); 95.6% (SEC-HPLC)
    Farbe und Form:Liquid